M E T H O D S I N M O L E C U L A R M E D I C I N ETM GGeennee TThheerraappyy ooff CCaanncceerr MMeetthhooddss aanndd PPrroottooccoollss EEddiitteedd bbyy WWoollffggaanngg WWaalltthheerr UUllrriikkee SStteeiinn HHuummaannaa PPrreessss Gene Therapy of Cancer M E T H O D S I N M O L E C U L A R M E D I C I N ETM John M. Walker, SERIES EDITOR 40. Diagnostic and Therapeutic 28. Cytotoxic Drug Resistance Antibodies,edited by Andrew J. T. Mechanisms, edited by Robert Brown George and Catherine E. Urch, 2000 and Uta Böger-Brown, 1999 39. Ovarian Cancer: Methods and 27. Clinical Applications of Capillary Protocols, edited by John M. S. Electrophoresis, edited by Stephen M. Bartlett, 2000 Palfrey, 1999 38. Aging Methods and Protocols, edited 26. Quantitative PCR Protocols, edited byYvonne A. Barnett and Christopher byBernd Kochanowski and Udo P. Barnett, 2000 Reischl, 1999 37. Electrically Mediated Delivery of 25. Drug Targeting, edited by G. E. Molecules to Cells, edited by Mark J. Francis and Cristina Delgado, 1999 Jaroszeski, Richard Heller, and Richard Gilbert, 2000 24. Antiviral Methods and Protocols, edited by Derek Kinchington 36. Septic Shock Methods and Protocols, and Raymond F. Schinazi, 1999 edited by Thomas J. Evans, 2000 23. Peptidomimetics Protocols, edited by 35. Gene Therapy of Cancer: Methods Wieslaw M. Kazmierski, 1999 and Protocols, edited by Wolfgang Walther and Ulrike Stein, 2000 22. Neurodegeneration Methods and Protocols, edited by Jean Harry 34. Rotavirus Methods and Protocols, and Hugh A. Tilson, 1999 edited by James Gray and Ulrich Desselberger, 2000 21. Adenovirus Methods and Protocols, edited by William S. M. Wold, 1998 33. Cytomegalovirus Protocols, edited by John Sinclair, 2000 20. Sexually Transmitted Diseases: Methods and Protocols, edited by 32. Alzheimer’s Disease: Methods and Rosanna Peeling and P. Frederick Protocols,edited by Nigel M. Hooper, 1999 Sparling, 1999 31. Hemostasis and Thrombosis 19. Hepatitis C Protocols, edited by Protocols:Methods in Molecular Johnson Yiu-Nam Lau, 1998 Medicine,edited by David J. Perry and K. John Pasi, 1999 18. Tissue Engineering, edited by Jeffrey R. Morgan and Martin L. 30. Vascular Disease: Molecular Biology Yarmush, 1999 and Gene Therapy Protocols, edited byAndrew H. Baker, 1999 17. HIV Protocols, edited by Nelson Michael and Jerome H. Kim, 1999 29. DNA Vaccines: Methods and Protocols,edited by Douglas B. 16. Clinical Applications of PCR, edited Lowrie and Robert Whalen, 1999 byY. M. Dennis Lo, 1998 M E T H O D S I N M O L E C U L A R M E D I C I N ETM Gene Therapy of Cancer Methods and Protocols Edited by Wolfgang Walther Max-Delbrück-Center for Molecular Medicine, Berlin, Germany and Ulrike Stein Max-Delbrück-Center for Molecular Medicine, Berlin, Germany Humana Press Totowa, New Jersey © 2000 Humana Press Inc. 999 Riverview Drive, Suite 208 Totowa, New Jersey 07512 All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher. Methods in Molecular Medicine™is a trademark of The Humana Press Inc. All authored papers, comments, opinions, conclusions, or recommendations are those of the author(s), and do not necessarily reflect the views of the publisher. This publication is printed on acid-free paper. (cid:39) ANSI Z39.48-1984 (American Standards Institute) Permanence of Paper for Printed Library Materials. Cover by Patricia Cleary For additional copies, pricing for bulk purchases, and/or information about other Humana titles, contact Humana at the above address or at any of the following numbers: Tel.: 973-256-1699; Fax: 973-256-8341; E-mail: [email protected]; Website: http://humanapress.com Photocopy Authorization Policy: Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Humana Press Inc., provided that the base fee of US $10.00 per copy, plus US $00.25 per page, is paid directly to the Copyright Clearance Center at 222 Rosewood Drive, Danvers, MA 01923. For those organizations that have been granted a photocopy license from the CCC, a separate system of payment has been arranged and is acceptable to Humana Press Inc. The fee code for users of the Transactional Reporting Service is: [0-89603-714-2 (hardcover) 089603-843-2 (combbound)/00 $10.00 + $00.25]. Printed in the United States of America. 10 9 8 7 6 5 4 3 2 1 Library of Congress Cataloging in Publication Data Main entry under title: Methods in molecular medicine™. Gene therapy of cancer : methods and protocols / edited by Wolfgang Walther and Ulrike Stein. p. cm. -- (Methods in molecular medicine ; 35) Includes bibliographical references and index. ISBN 0-89603-714-2 (hard : alk. paper). --ISBN 0-89603-843-2 (comb : alk. paper) 1. Cancer--Gene therapy Laboratory manuals. I. Walther, Wolfgang. II. Stein, Ulrike. II. Series [DNLM: 1. Neoplasms--therapy. 2. Gene Therapy--methods. QZ 266 G3259 2000] RC271.G45G484 2000 616.99'4042--dc21 DNLM/DLC for Library of Congress 99-38474 CIP Preface Since the discovery of the molecular structure of genes and the unveiling of the molecular basis of numerous human diseases, scientists have been fasci- nated with the possibility of treating certain diseases by transducing foreign DNA into the affected cells. Initially, it was proposed that the foreign DNA could either replace defective nonfunctional genes, or code for therapeutic proteins. This concept has evolved into the rapidly growing field of gene therapy. Even though surgery, radiotherapy, and chemotherapy are widely avail- able and routinely used for cancer treatment, these therapies fail to cure approximately 50 percent of cancer patients. Therefore, since it is a disease characterized by aberrant gene expression, cancer has been a target of gene therapy research since the inception of this treatment modality. Numerous cancer gene therapy strategies are currently being investigated, including gene replacement therapy, the regulation of gene expression to modulate immuno- logical responses to tumors, the direct killing of tumor cells, and direct inter- ference with tumor growth. In this context, gene transfer systems, tumor-specific expression vectors, and novel therapeutic genes have been extensively stud- ied. All these strategies aim for the selective destruction of human malignant disease while circumventing the destruction of nonmalignant cells and tissues thereby minimizing toxicity to the patient. Rapid progress in the field of cancer gene therapy, exemplified by the vast number of publications in this area, creates a challenging situation for scientists and clinicians who need to be cognizant of the most recent advances in gene transfer techniques. This volume of Gene Therapy of Cancer: Meth- ods and Protocols in the Methods in Molecular Medicine series will provide researchers with a broad array of methods used to study cancer gene therapy inboth the laboratory and clinical trials. Moreover, several chapters are included to provide short overviews of specialized gene therapy strategies for the treat- ment of particular malignancies. Gene Therapy of Cancer: Methods and Protocolsdoes not provide com- prehensive reviews of all methodologies currently used for gene therapy of cancer. Rather the topics we have selected consist of approved procedures, v vi Preface current trends, and representative strategies in cancer gene therapy using dif- ferent classes of therapeutic genes, suppressor genes, antisense oligonucle- otides, ribozymes, viral- and nonviral-vector systems, and tumor targeting approaches at the preclinical and, more importantly, at the clinical level. For cancer gene therapy to be successful in the treatment of human cancers, exten- sive preclinical evaluation is essential. Therefore, the first part of this book discusses relevant experiments from preclinical studies followed by clinical gene therapy protocols in the second part. Gene Therapy of Cancer: Methods and Protocolsshould provide practi- cal guidance for basic and clinical researchers, as well as graduate and post- graduate students working in the exciting and emerging field of gene therapy. Wolfgang Walther Ulrike Stein Contents Preface .............................................................................................................v Contributors.....................................................................................................xi PART I. EXPERIMENTAL APPROACES TO CANCER GENE THERAPY A:Immunotherapy/Tumor Vaccination 1 Immunizing Potential of Cytokine-Transduced Tumor Cells Mario P. Colombo and Monica Rodolfo..............................................3 2 Particle-Mediated Gene Transfer into Dendritic Cells: A Novel Strategy for the Induction of Immune Responses against Tumor Antigens Thomas Tüting and Andreas Albers.................................................27 3 Cancer Gene Therapy with Heat Shock Protein-65 Gene Katalin V. Lukacs and Artit Nakakes.................................................49 4 Recombinant Vaccinia Virus MVA for Generation and Analysis of T Cell Responses Against Tumor Associated Antigens Ingo Drexler, Karl Heller, Marion Ohlmann, Volker Erfle, and Gerd Sutter...............................................................................57 B:Suicide Gene Therapy 5 Selection of Cytochrome P450 Genes for Use in Prodrug Activation-Based Cancer Gene Therapy Jodi E. D. Hecht and David J. Waxman............................................77 6 Construction of P450-Expressing Tumor Cell Lines Using Retroviruses Jodi E. D. Hecht, Youssef Jounaidi, and David J. Waxman.....................................................................85 7 In Vitro Methods for Evaluation of P450-Based Anticancer Gene Therapy Jodi E. D. Hecht and David J. Waxman............................................95 8 Tumor Models for Evaluation of P450 Gene Therapy In Vivo Jodi E. D. Hecht, Pamela Schreiber Schwartz, and David J. Waxman...................................................................107 vii viii Contents C:Anti-Oncogene and Suppressor Gene Therapy 9 Intracellular Single-Chain Antibodies for Gene Therapy Guadalupe Bilbao, Jesus Gomez-Navarro, Keizo Kazano, Juan Luis Contreras, and David T. Curiel..................................121 10 Combined Adenoviral Transfer of Tumor Suppressor and Cell-Cycle Genes for Tumor-Cell Apoptosis Karsten Brand, Volker Sandig, and Michael Strauss....................151 D:Antisense Gene Therapy 11 Inhibition of Cell Growth by Antisense Oligonucleotides Targeting the Growth-Related Protein Kinase c-raf Doriano Fabbro, B. P. Monia, K.-H. Altmann, and Thomas Geiger.......................................................................167 12 IGF-1 Antisense Strategies for Cancer Treatment Yue Xin Pan and Donald D. Anthony..............................................189 E:Ribozyme Gene Therapy 13 Anti-MDR1 Ribozyme Gene Therapy Takao Ohnuma, Hiroyuki Kobayashi, and Fu-Sheng Wang.........207 14 Anti-c-erbB2 Ribozyme for Gene Therapy of Breast Cancer Toshiya Suzuki, Masami Bessho, and Kevin J. Scanlon.............247 15 Anti-K-ras Ribozyme Adenoviral Vector for Gene Therapy of Non-Small Cell Lung Cancer Yu-An Zhang, John Nemunaitis, and Alex W. Tong......................261 F:Delivery Systems and Tumor Targeting 16 Green Fluorescent Protein Retroviral Vector: Generation of High-Titer Producer Cells and Virus Supernatant Wolfgang Uckert, Lene Pedersen, and Walter Günzburg............275 17 HSV-1 Vectors for Gene Therapy of Experimental CNS Tumors Ulrich Herrlinger, Andreas Jacobs, Manish Aghi, Deborah E. Schuback, and Xandra O. Breakefield...................287 18 Intratumoral Injection of Naked DNA Jingping Yang....................................................................................313 19 Cationic Liposome Gene Transfer Kyonghee Kay Son............................................................................323 20 In Vivo Particle-Mediated Gene Transfer for Cancer Therapy Alexander L. Rakhmilevich and Ning-Sun Yang...........................331 Contents ix 21 Gene Targeting to Hepatomas (AFP) Shotaro Tsuruta, Akio Ido, and Shigenobu Nagataki...................345 22 Adenovirus-Mediated Targeted Gene Therapy for Breast Cancer and for Purging Hematopoietic Stem-Cell Sources Ling Chen............................................................................................361 23 Chemotherapy-Inducible Vector for Gene Therapy of Cancer Wolfgang Walther, Ulrike Stein, Robert H. Shoemaker, and Peter M. Schlag......................................................................371 G:Alternative Approaches in Cancer Gene Therapy 24 Oncolytic Adenoviral Vectors Ramon Alemany and Wei-Wei Zhang..............................................395 25 Genetically Modified Clostridium for Gene Therapy of Tumors Mary E. Fox, Marilyn J. Lemmon, Amato J. Giaccia, Nigel P. Minton, and J. Martin Brown.........................................413 26 Tumor-Targeted Salmonella:Strain Development and Expression of the HSV-tK Effector Gene David Bermudes, Brooks Low, and John M. Pawelek..................419 Part II. Clinical Protocols for Cancer Gene Therapy A:Immunotherapy/Tumor Vaccination 27 Ex Vivo Cytokine Gene Transfer in Melanomas by Using Particle Bombardment Dirk Schadendorf...............................................................................439 28 Intratumoral Gene Transfer of the HLA-B7 Gene Into Colon Carcinoma Metastases Evanthia Galanis and Joseph Rubin...............................................453 29 Hybrid Cell Vaccination in Patients with Metastatic Melanoma Uwe Trefzer, Guido Weingart, Wolfram Sterry, and Pete Walden............................................................................469 B:Suicide Gene Therapy 30 Retroviral Transfer of the Herpes Simplex Virus-Thymidine Kinase (HSV-tK) Gene for the Treatment of Cancer Rajagopal Ramesh, Anupama Munshi, Aizen J. Marrogi, and Scott M. Freeman...................................................................479 31 Gene Therapy for Treatment of Brain Tumors (HSV-tK In Vivo Gene Transfer): A Case Study Friedrich Weber, Frank Floeth, and Hans Bojar............................499